Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report

Sorafenib is a tyrosine kinase inhibitor that has been demonstrated to improve the overall survival time of patients with advanced hepatocellular carcinoma (HCC). Although there have been a number of reports of patients achieving complete remission (CR) following sorafenib therapy, the long-term cli...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: Park, Jung Gil, Tak, Won Young, Park, Soo Young, Kweon, Young Oh, Jang, Se Young, Lee, Soo Hyun, Lee, Yu Rim, Jang, Sun Kyung, Hur, Keun, Lee, Heon Ju
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2017
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5649582/
https://ncbi.nlm.nih.gov/pubmed/29085491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6788
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia